ARTICLES |
|
Year : 2005 | Volume
: 11
| Issue : 1 | Page : 28-34 |
|
Angiogenic effects of leptin in patients with nonalcoholic steatohepatitis
Nagah Kamel Gaafar1, El-Sayed Ahmed Wasfi2, Yehia Ahmed El- Mashad1, Saad-El-Din Abd-El-Fattah Abou-El Noeman3, Mohamed Ahmed Hassanien1
1 Department of Medical Biochemistry, Faculty of Medicine, Tanta University, Tanta, Egypt 2 Department of Tropical Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt 3 Department of Biochemistry, King Khalid University Hospital, Riyadh, Saudi Arabia
Correspondence Address:
Saad-El-Din Abd-El-Fattah Abou-El Noeman Department of Medical Biochemistry, College of Medicine, King Saud University. P 0 Box 2925. Riyadh Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1319-3767.33334
|
|
Background: Nonalcoholic steatohepatitis (NASH) is characterized by morphological features indistinguishable from alcoholic hepatitis in individuals who do not consume excess alcohol. The role of leptin in the development of NASH is claimed to be through its inflammatory, fibrogenic and angiogenic effects.
Aim of the study: to evaluate the leptin status in patients with NASH with the emphasis on its angiogenic effects and its relation to basic fibroblast growth (BFGF). Patients and Methods: This study was conducted on twentyfive patients with NASH and twenty normal persons of matched age and sex as control. For both groups, lipid profile, fasting and postprandial blood glucose, Serum leptin and BFGF were determined. All the results were tabulated and statistically evaluated.
Results: Obesity, hyperlipidaemia and diabetes mellitus were prevalent among patients with NASH. There were significant increase of leptin and basic fibroblast growth factor in patients with NASH, as compared to control.
Conclusion: Leptin plays an important role in the pathogenesis of NASH through its metabolic, fibrogenic and angiogenic effects. It may also have a role in the development of complications |
|
|
|
[FULL TEXT] [PDF Not available]* |
|
 |
|